Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 2
2009 1
2010 4
2011 8
2012 7
2013 8
2014 10
2015 13
2016 19
2017 14
2018 13
2019 14
2020 20
2021 19
2022 14
2023 15
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Results by year

Filters applied: . Clear all
Page 1
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.
CRASH-2 trial collaborators; Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Gogichaishvili T, Gupta S, Herrera J, Hunt B, Iribhogbe P, Izurieta M, Khamis H, Komolafe E, Marrero MA, Mejía-Mantilla J, Miranda J, Morales C, Olaomi O, Olldashi F, Perel P, Peto R, Ramana PV, Ravi RR, Yutthakasemsunt S. CRASH-2 trial collaborators, et al. Lancet. 2010 Jul 3;376(9734):23-32. doi: 10.1016/S0140-6736(10)60835-5. Epub 2010 Jun 14. Lancet. 2010. PMID: 20554319 Clinical Trial.
The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial.
CRASH-2 collaborators; Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. CRASH-2 collaborators, et al. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. doi: 10.1016/S0140-6736(11)60278-X. Lancet. 2011. PMID: 21439633 Clinical Trial.
Pilocytic astrocytoma.
Lourenço EP, Nzwalo H, Sampaio MR, Varela AV. Lourenço EP, et al. Among authors: varela av. BMJ Case Rep. 2016 Mar 31;2016:bcr2015213013. doi: 10.1136/bcr-2015-213013. BMJ Case Rep. 2016. PMID: 27033282 Free PMC article. No abstract available.
Bacterial Metalo-Aminopeptidases as Targets in Human Infectious Diseases.
González-Bacerio J, Varela AC, Aguado ME, Izquierdo M, Méndez Y, Del Rivero MA, Rivera DG. González-Bacerio J, et al. Among authors: varela ac. Curr Drug Targets. 2022;23(12):1155-1190. doi: 10.2174/1389450123666220316085859. Curr Drug Targets. 2022. PMID: 35297344 Review.
Parasite Metalo-aminopeptidases as Targets in Human Infectious Diseases.
Aguado ME, Izquierdo M, González-Matos M, Varela AC, Méndez Y, Del Rivero MA, Rivera DG, González-Bacerio J. Aguado ME, et al. Among authors: varela ac. Curr Drug Targets. 2023;24(5):416-461. doi: 10.2174/1389450124666230224140724. Curr Drug Targets. 2023. PMID: 36825701 Review.
Trauma and the endocrine system.
Mesquita J, Varela A, Medina JL. Mesquita J, et al. Among authors: varela a. Endocrinol Nutr. 2010 Dec;57(10):492-9. doi: 10.1016/j.endonu.2010.06.012. Epub 2010 Sep 17. Endocrinol Nutr. 2010. PMID: 20850396 Review.
Challenges in Chronic Myeloid Leukemia Management in South America.
Pagnano KB, Varela AI, Pavlovsky C, Bendit I, Funke VAM, Polo VA. Pagnano KB, et al. Among authors: varela ai. Curr Hematol Malig Rep. 2021 Oct;16(5):440-447. doi: 10.1007/s11899-021-00654-0. Epub 2021 Oct 15. Curr Hematol Malig Rep. 2021. PMID: 34655027 Review.
Using microbial metalo-aminopeptidases as targets in human infectious diseases.
González-Bacerio J, Izquierdo M, Aguado ME, Varela AC, González-Matos M, Del Rivero MA. González-Bacerio J, et al. Among authors: varela ac. Microb Cell. 2021 Aug 9;8(10):239-246. doi: 10.15698/mic2021.10.761. eCollection 2021 Oct 4. Microb Cell. 2021. PMID: 34692819 Free PMC article. Review.
In-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Sanchez MB, Vasconcelos Cordoba B, Pavlovsky C, Moiraghi B, Varela A, Custidiano R, Fernandez I, Freitas MJ, Ventriglia MV, Bendek G, Mariano R, Mela Osorio MJ, Pavlovsky MA, García de Labanca A, Foncuberta C, Giere I, Vera M, Juni M, Mordoh J, Sanchez Avalos JC, Levy EM, Bianchini M. Sanchez MB, et al. Among authors: varela a. Front Immunol. 2023 Sep 25;14:1241600. doi: 10.3389/fimmu.2023.1241600. eCollection 2023. Front Immunol. 2023. PMID: 37818372 Free PMC article. Clinical Trial.
Index of suspicion.
Bekmezian A, Lasky JL 3rd, Osman S, Kaddurah AK, Varela AM, Velez K, Alvarez O. Bekmezian A, et al. Among authors: varela am. Pediatr Rev. 2009 Aug;30(8):311-6. doi: 10.1542/pir.30-8-311. Pediatr Rev. 2009. PMID: 19648262 No abstract available.
163 results